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Abstract 35 
Microtubules are polymers of tubulin dimers, and conformational transitions in the microtubule 36 
lattice drive microtubule dynamic instability and affect various aspects of microtubule function. 37 
The exact nature of these transitions and their modulation by anti-cancer drugs such as Taxol and 38 
epothilone, which can stabilize microtubules but also perturb their growth, are poorly understood. 39 
Here, we directly visualize the action of fluorescent Taxol and epothilone derivatives and show 40 
that microtubules can transition to a state that triggers cooperative drug binding to form regions 41 
with altered lattice conformation. Such regions emerge at growing microtubule ends that are in a 42 
pre-catastrophe state and inhibit microtubule growth and shortening. Electron microscopy and in 43 
vitro dynamics data indicate that taxane accumulation zones represent incomplete tubes that can 44 
persist, incorporate tubulin dimers and repeatedly induce microtubule rescues. Thus, taxanes 45 
modulate the material properties of microtubules by converting destabilized growing microtubule 46 
ends into regions resistant to depolymerization.   47 
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Microtubules are cytoskeletal filaments essential for numerous cellular functions. They are 48 
formed by the polymerization of tubulin dimers into a regular lattice1. Microtubule lattices 49 
display structural plasticity, which means that they can adopt multiple conformational states with 50 
different protofilament arrangements, curvature and extent of tube closure2,3. Transitions between 51 
these states can be controlled by the nucleotide state of tubulin, by tubulin isoforms and 52 
modifications, and by local mechanical strain and binding of proteins and drugs2-4. 53 
Taxol (the brand name of the drug paclitaxel) is a microtubule-targeting agent (MTA) that is 54 
broadly used for cancer therapy5-7. Taxol stabilizes microtubules by binding to a luminally 55 
exposed β-tubulin site, which is shared by other microtubule-stabilizing agents6-8. Taxol has been 56 
shown to straighten individual microtubule protofilaments9, and cryo-electron microscopy (cryo-57 
EM) analysis indicated that Taxol allosterically affects longitudinal interfaces between tubulin 58 
dimers by counteracting microtubule lattice compaction induced by GTP hydrolysis10-12. 59 
Furthermore, analysis of MTA interactions with unpolymerized tubulin showed that some taxane-60 
site ligands, such as epothilone A, affect the structure of the β-tubulin M-loop, which contributes 61 
to the lateral interactions between tubulin dimers13-15. The notion that taxane-site binding 62 
compounds stabilize lateral tubulin interactions is supported by a recent cryo-EM study16. While 63 
these structural insights explain how these MTAs stabilize microtubules at saturating 64 
(micromolar) concentrations, they do not account for the drug effects at lower concentrations, 65 
which potently suppress both microtubule growth and shortening5. Understanding such effects is 66 
of crucial importance, because they represent the clinically relevant situation as the concentration 67 
of Taxol in plasma during chemotherapy was estimated to be in the range between tens and a few 68 
hundred nanomolar17-20. 69 
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Our previous work has shown that non-saturating Taxol concentrations (50-100nM) can promote 70 
catastrophes induced in vitro by the End Binding (EB) family proteins21. Catastrophe potentiation 71 
by low Taxol concentrations is readily observed in cells (for an example, see22). In line with these 72 
data, low concentrations of Taxol and microtubule-destabilizing vinca alkaloids synergize rather 73 
than counteract each other in inhibiting cancer cell proliferation23, in spite of having seemingly 74 
opposite mechanisms of action. Low Taxol concentrations thus do not increase overall 75 
microtubule stability; however, they do cause formation of discrete sites that block microtubule 76 
shrinkage and induce repeated rescues21. To understand how such rescue sites are formed, we 77 
visualized drug binding during microtubule growth using fluorescent taxane-site ligands. We 78 
found that these MTAs cooperatively bind to microtubule tips that are in a pre-catastrophe state 79 
and convert them into islands of stabilized microtubule lattice .  80 
 81 
Taxane accumulations induce repeated microtubule rescues  82 
To directly visualize the effects of taxanes on microtubule dynamics, we used two green 83 
fluorescent Taxol derivatives, Fchitax-3 and Flutax-2 24,25 (Supplementary Fig. 1a). We used a 84 
Total Internal Reflection Fluorescence microscopy (TIRFM)-based assay, in which microtubule 85 
seeds stabilized with the slowly hydrolysable GTP analogue GMPCPP are extended in the 86 
presence of soluble tubulin with or without other proteins or drugs21,26 (Supplementary Fig. 1b,c). 87 
Whereas almost no rescues occurred either with tubulin alone or in the presence of mCherry-88 
EB3, we observed frequent rescues in the presence of Taxol and its fluorescent derivatives (Fig. 89 
1a-d, Supplementary Fig. 1c-e). As described previously21, these rescues typically happened at 90 
defined microtubule lattice sites, which we termed “stable rescue sites” (Fig. 1a-c, Supplementary 91 
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Fig. 1d). Importantly, in the case of fluorescent taxanes, we observed a ~4 fold enhanced drug 92 
binding at such sites as compared to the rest of the microtubule lattice (Fig. 1b,c). Similar sites 93 
with increased drug accumulation inducing repeated rescues could also be detected in HeLa cells 94 
that expressed EB3-TagRFP as a microtubule plus-end marker and were incubated with 100nM 95 
Fchitax-3 for 1hr (Fig. 1e). Comparison of the intensities of single Fchitax-3 molecules and of 96 
very short Fchitax-3 accumulations at the stable rescue sites in vitro showed that they contained 97 
~15 molecules (Supplementary Fig. 1f-j). Taxane-induced formation of stable rescue sites thus 98 
occurs both in vitro and in cells, and ~15 drug molecules are sufficient to induce such a site. 99 
 100 
Taxane accumulations initiate at microtubule ends  101 
While observing microtubule growth in the presence of fluorescent taxanes, we noticed that the 102 
compounds always started to accumulate close to the growing microtubule plus or minus ends, 103 
directly behind the EB3-positive comet (Fig. 2a,b, Supplementary Fig. 2a, Supplementary Video 104 
1). Taxane accumulation events appeared in a stochastic manner (Supplementary Fig. 2b) and 105 
were somewhat more prolonged and more frequent at the minus ends (Fig. 2a,b, Supplementary 106 
Fig. 2a,c). For subsequent work, we focused on drug accumulations at the plus ends, as minus 107 
ends typically do not elongate much in vivo27. Consistent with the in vitro data, transient 108 
accumulations of Fchitax-3 were also observed at growing microtubule plus ends in cells 109 
(Supplementary Fig. 2d,e).  110 
To test whether end-dependent binding was specific for Taxol analogues, we generated an Alexa-111 
488-labeled derivative of epothilone B (Supplementary Fig. 1a, Supplementary Fig. 3a,b), a 112 
different taxane-site binder, and found that it exhibited similar accumulations at growing 113 
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microtubule ends (Fig. 2c). The drug accumulations also occurred in the absence of EB3 (Fig. 2d, 114 
Supplementary Fig. 2f); however, since EBs facilitate the detection of growing microtubule tips, 115 
subsequent experiments were carried out in the presence of EB3. During periods of strong drug 116 
accumulation, microtubule growth was perturbed, as could be seen by the reduction of EB3 117 
signal and the microtubule growth rate (Fig. 2a,c-g). After a brief interval, an accumulation could 118 
abruptly stop and normal microtubule growth could resume (Fig. 2a,c-g). Concomitantly, the 119 
region of enhanced drug binding persisted in the microtubule lattice (Fig. 2a,c,d). If such a 120 
growing microtubule started shrinking, microtubule depolymerization was arrested within the 121 
region with a high drug concentration, leading to rescue, which was often observed repeatedly at 122 
the same site (Fig. 2a,c, Supplementary Fig. 2a). Microtubule polymerization with periods of 123 
perturbed growth and subsequent frequent rescues initiating within the same microtubule region 124 
was also observed with Taxol, with and without EB3 (Supplementary Fig. 2g,h). Such a behavior 125 
is thus representative for taxane-site MTAs and is not an artifact of fluorescently labeled drugs. 126 
To confirm that regions with high taxane accumulation have an increased stability, we performed 127 
laser severing experiments. Whereas control microtubules always depolymerized at the newly 128 
generated plus- and minus-ends (Supplementary Fig. 2i), the presence of an Fchitax-3 129 
accumulation prevented shrinkage of freshly severed ends (Fig. 2h, Supplementary Video 2). 130 
These data demonstrate that increased taxane incorporation initiated close to a growing 131 
microtubule end leads to stabilization of a stretch of microtubule lattice. 132 
 133 
Taxane accumulations are triggered by growth perturbations 134 
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Since microtubule minus ends grow slower than plus ends and show longer and more frequent 135 
Fchitax-3 accumulations (Supplementary Fig. 1c, 2c), we initially hypothesized that the drugs can 136 
accumulate more easily at their luminal binding sites if microtubule polymerization is slow. 137 
However, when we varied tubulin concentration to alter the growth speed (Supplementary Fig. 138 
4a,b), we found that in fact Fchitax-3 accumulations became more frequent when microtubules 139 
grew faster (Fig. 3a,b, Supplementary Fig. 4c). At higher growth rates, the length of Fchitax-3 140 
accumulations increased (Fig. 3a,b, Supplementary Fig. 4c). In our assays, in the presence of EB3 141 
without MTAs, increased tubulin concentrations led to a higher catastrophe frequency, although 142 
at 25µM tubulin, we did observe some microtubules that were persistently elongating 143 
(Supplementary Fig. 4a); importantly, such microtubules still displayed frequent growth 144 
perturbations that appeared as a catastrophe followed by a rapid rescue (Supplementary Fig. 145 
4a,b).  146 
Interestingly, we noticed that Fchitax-3 accumulations were often initiated when microtubule 147 
polymerization appeared suboptimal or perturbed, which was often observed at microtubule 148 
minus ends (Supplementary Fig. 1c, Fig. 2b), or when the plus end of a GMPCPP seed just 149 
started to elongate (Supplementary Fig. 4d). Fchitax-3 accumulation events were always 150 
accompanied by a decrease in microtubule growth rate and the concomitant loss in EB3 signal 151 
(Fig. 2e-g). Analysis of the onset of such events with a higher temporal resolution and careful 152 
alignment of the Fchitax-3 and EB3 channels showed that on processively growing microtubules, 153 
the appearance of a new Fchitax-3 accumulation occurred ~5s after a clear reduction in EB3 154 
signal (Fig. 3c-e). The reduction in the number of EB3-binding sites at the growing microtubule 155 
end is a hallmark of the pre-catastrophe state28 (Supplementary Fig. 4e). Furthermore, the 156 
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frequencies of catastrophes and of appearance of Fchitax-3 accumulations at the growing 157 
microtubule ends are similar (Supplementary Fig. 4f).  158 
We therefore wondered whether Fchitax-3 accumulations could be triggered by changes in the 159 
microtubule end conformation that lead to catastrophe. Catastrophes can be potently stimulated in 160 
our in vitro assays by different microtubule-depolymerizing agents, such as vinblastine21 or by 161 
kinesin-13 family protein mitotic centromere-associated kinesin (MCAK)29. The addition of  162 
GFP-MCAK, which specifically tracked growing EB3-positive microtubule ends, or vinblastine 163 
reduced microtubule growth rate and indeed promoted catastrophes (Supplementary Fig. 4g). 164 
These conditions are somewhat reminiscent of the dynamics of microtubule minus ends, which 165 
exhibit frequent growth perturbations (Supplementary Fig. 1c, 4g). Interestingly, the addition of  166 
vinblastine or GFP-MCAK increased the frequency of Fchitax-3 or Alexa488-epothilone B 167 
accumulations, as well as the occurrence of stable rescue sites with or without EB3 (Fig. 3f-i, 168 
Supplementary Fig. 4h,i). A similar pattern of microtubule plus end growth with frequent 169 
perturbations and repeated rescues was also observed with the combination of vinblastine and 170 
Taxol (Fig. 3j), indicating that the behavior of fluorescent compounds is representative for 171 
taxane-site binders. It should be emphasized that vinblastine can bind to free tubulin and to the 172 
outmost microtubule tips30, but cannot be incorporated into microtubule lattices and directly 173 
influence the conformation of the taxane-binding site within microtubule shafts. MCAK also acts 174 
at the outmost microtubule tips and is not expected to influence microtubule lattice structure31. 175 
Together, these data show that the perturbed structure of a microtubule end associated with the 176 
pre-catastrophe state induces formation of lattice regions with enhanced taxane accumulation. 177 
 178 
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Analysis of Fchitax-3 binding kinetics  179 
To understand better how Fchitax-3 accumulations are formed, we analyzed their dynamics in 180 
more detail. After the binding was initiated, Fchitax-3 intensity on the microtubule first rapidly 181 
increased over the course of ~50s, and then, after a period of ~100s, it abruptly started to 182 
diminish (Fig. 4a). The rapid decline of Fchitax-3 intensity within the accumulation zone was not 183 
caused by photobleaching (Supplementary Fig. 5a, see figure legend for details), and thus was 184 
due to drug dissociation from the microtubule. 185 
The shape of the kinetic curve, with a rapid rise and a subsequent decline, suggests that some 186 
tubulin dimers first acquire an ability to bind Fchitax-3 (the initial drug accumulation phase), but 187 
later are converted to a state lacking this ability (the drug desorption phase). Because Fchitax-3 188 
binding does not happen throughout the entire period of microtubule growth, but emerges at the 189 
ends that are in a pre-catastrophe state, we defined two subsets of tubulins present at microtubule 190 
ends, which have different ability to interact with Fchitax-3: Tureceptive and Tuunreceptive. To account 191 
for desorption, we assumed that these states can be turned into the microtubule lattice-specific 192 
conformational state that does not bind to Taxol in these conditions (Tulattice).  193 
To model the kinetics of Fchitax-3 accumulation and unbinding, we first used a Michaelis-194 
Menten type of model, in which Taxol was taken as a ‘catalyst’ that binds Tureceptive (the 195 
‘‘substrate’) that subsequently converts irreversibly to a non-Taxol-binding state within the 196 
microtubule lattice (Tulattice, the ‘product’). However, this model provided a poor fit to 197 
experimentally obtained binding curve (Fig. 4b,c, Supplementary Fig. 5b,c). To account for the 198 
rapid and sustained increase in drug accumulation, we introduced an autocatalytic step (Fig. 4b), 199 
in which binding of Taxol to Tureceptive can trigger the conversion of unreceptive tubulin at 200 
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microtubule ends to receptive tubulin (Fig. 4a-c, Supplementary Fig. 5d-g, see Methods for 201 
details). The obtained rate constant of Fchitax-3 binding (k1, 5.6±0.5 x105 M-1s-1) was in good 202 
agreement with previously reported measurements for Flutax-1 and Flutax-2 24,32, whereas the 203 
rate constant of dissociation was an order of magnitude lower (k-1, 1.4±0.2 x10-2 s-1, Fig. 4d). This 204 
is consistent with the fact that the affinity of Fchitax-3 for its binding site is an order of 205 
magnitude higher than that of Flutax-2 24,25.  206 
Next, we explored how the kinetic parameters changed along the length of the microtubule zone 207 
where an accumulation happened. In our dynamics assays, the maximum Fchitax-3 intensity 208 
observed over time was typically higher at the initial point of the accumulation compared to its 209 
distal end, which was formed later (Fig. 4a). In the model, this was reflected by the diminishing 210 
number of tubulin dimers per unit of microtubule length that could interact with the drug 211 
(Supplementary Fig. 5d). Furthermore, FRAP data showed that the recovery of Fchitax-3 at the 212 
starting point of an accumulation was higher compared to the distal end of an accumulation (Fig. 213 
4e), and this fitted well with the modeling results (Fig. 4c,f). The higher number of drug binding 214 
sites at the starting point of Fchitax-3 accumulation was in agreement with the observation that 215 
this region was often most resistant to depolymerization (see Fig. 3c for an example). Thus, the 216 
conformation of the microtubule zone with a high taxane affinity was changing along the 217 
growing microtubule. This could be due to some global alterations in microtubule geometry, such 218 
as a gradual closure of an open tubulin sheet. In the model, this was reflected by the variability of 219 
the autocatalysis rate constant k2 (Fig. 4d), which can be expected to be affected by tubulin 220 
conformation in the microtubule lattice.  221 
Quantification of the density of Fchitax-3 molecules during maximal accumulation along 222 
microtubule stretches of ~900nm length showed that ~1-2 drug molecules were bound per 8nm, 223 
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the length of one tubulin dimer (Supplementary Fig. 5h). Since GMPCPP-nucleated microtubules 224 
in our assays are expected to have ~14 protofilaments, this means that even at the highest binding 225 
density the microtubule is still far from being saturated with the drug. It should be noted that 226 
since this quantification is based on the average fluorescence intensity, it is possible that Fchitax-227 
3 molecules are distributed in an irregular fashion, for example, with neighboring tubulin 228 
subunits being preferentially in either bound or unbound state. Combined with the modeling, our 229 
data suggest that taxanes display cooperative binding to microtubules even at low saturation, 230 
suggesting that changes in drug binding affinity can propagate in microtubule lattices. 231 
 232 
Nucleotide state of tubulin affects Fchitax-3 binding  233 
Since growing microtubule ends maintain a GTP cap that is gradually hydrolyzed, and since 234 
tubulin undergoes nucleotide-dependent conformational changes10,16,33, enhanced Fchitax-3 235 
binding at growing microtubule tips could be due to a particular nucleotide state. Fchitax-3 and 236 
other tested taxanes indeed showed preference for GMPCPP seeds and GMPCPP-containing 237 
microtubule extensions as compared to GDP-bound lattices (Fig. 5a,b). FRAP analysis of 238 
Fchitax-3 signal on GMPCPP seeds provided an estimate for the dissociation constant (k-1 FRAP, 239 
2.2±0.3 x10-2 s-1), which was similar to the values derived from our autocatalysis kinetic model 240 
(Fig. 5c,d). In contrast, Fchitax-3 had no preference for GTPγS-bound microtubules, which are 241 
thought to mimic the GTP-Pi state of tubulin11,33 (Fig. 5e).  242 
Preferential binding to GMPCPP microtubules might be due to their longitudinally extended 243 
lattice conformation, because Taxol was reported to induce similar microtubule lattice extension 244 
if added during though not after microtubule assembly11,16,33,34. To get support for the idea that 245 
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Taxol affects tubulin dimer length within microtubules, we performed X-ray fiber diffraction 246 
experiments with microtubules that were assembled from GTP-tubulin and were either untreated 247 
or treated with Taxol during or after polymerization (Supplementary Fig. 6a-e).  Both Taxol-248 
treated samples exhibited an increased dimer length compared to drug-free microtubules, though 249 
this length was slightly shorter in samples treated with Taxol after assembly (Supplementary Fig. 250 
6f,g). Similarly, microtubules assembled from GDP-tubulin incubated with Taxol during 251 
polymerization also displayed extended lattice (Supplementary Fig. 6d-g) (note that GDP-tubulin 252 
does not polymerize without Taxol and, therefore, the effect of Taxol could not be tested in the 253 
post-assembly conditions).  Taxol can thus induce changes in microtubule lattice compaction that 254 
could contribute to the observed binding preferences and cooperativity. However, the maximum 255 
intensity of Fchitax-3 accumulations at microtubule ends greatly exceeded the intensity of the 256 
drug binding to GMPCPP-stabilized seeds present in the same microtubules (Fig. 5a). 257 
Furthermore, Fchitax-3 accumulations could also form at microtubule tips in the presence of 258 
GTPγS, although in this case their intensity was typically lower than that at GMPCPP-containing 259 
microtubule seeds in the same assay (Fig. 5e). We therefore conclude that the nucleotide state of 260 
tubulin and the associated changes in the longitudinal lattice compaction can affect taxane 261 
binding, but they are not sufficient to explain the strong drug accumulations at microtubule ends. 262 
In particular, rapid release of Fchitax-3 from the accumulation zones and the abrupt transitions 263 
between regions of high and low drug binding can be best explained by additional global 264 
conformational transitions, such as the closure of a microtubule sheet into a tube.  265 
 266 
Taxanes induce tube closure defects  267 
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To investigate whether the presence of taxane accumulations is indeed associated with deviations 268 
in microtubule structure, we performed a cryo-EM analysis of GMPCPP-stabilized microtubule 269 
seeds, control microtubules, microtubules grown in the presence of either  Fchitax-3 or 270 
vinblastine, or both agents together (Fig. 6a-d, Supplementary Fig. 7a-c). GMPCPP stabilized 271 
microtubule seeds showed a regular geometry with very few, small defects (< ~40nm) 272 
(Supplementary Fig. 7a). Whereas Fchitax-3 had no effect on the abundance of small microtubule 273 
defects (<~40nm), we observed in its presence a significant increase in the frequency of 274 
incomplete microtubule shaft regions that were longer than 40nm (Fig. 6a-d). Very long regions 275 
of incomplete microtubule lattices were seen when Fchitax-3 and vinblastine were combined 276 
(Supplementary Fig. 7b,c). These data strongly suggest that the regions of enhanced Fchitax-3 277 
binding represent microtubule regions that failed to close into a complete microtubule tube. 278 
Incomplete microtubule lattice structures are expected to show increased flexibility, and we 279 
indeed observed a strong increase in transverse microtubule tip fluctuations during formation of 280 
Fchitax-3 accumulations (Fig. 6e). It should be noted that Taxol binding can by itself reduce 281 
microtubule rigidity34-36, and it is possible that this effect contributes to the flexible character of 282 
the Fchitax-3 accumulation zones. 283 
To confirm that Fchitax-3-grown microtubules contain interrupted protofilaments,  we used as a 284 
tool the microtubule minus-end binding protein CAMSAP3. CAMSAPs recognize free 285 
microtubule minus ends because their signature domain, CKK, binds in a minus-end specific 286 
manner to interprotofilament sites at uncapped microtubule extremities37. Interestingly, distinct 287 
CAMSAP3 binding was observed at ~30% of Fchitax-3 accumulations (Fig. 6f, Supplementary 288 
Fig. 7d). Over time, the CAMSAP3 signal extended in the minus end direction (Fig. 6f). Since 289 
CAMSAPs decorate growing microtubule minus ends38, these data indicate that Fchitax-3 290 
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accumulations can create regions of incomplete microtubule lattice that can be extended by 291 
tubulin addition. These data also explain why Fchitax-3 accumulation zones can serve as origin 292 
of EB3-positive comets (Fig. 3f,h, white arrows in EB3 panels), which highlight growing 293 
protofilament plus- and minus-ends. Similar events were also observed in the presence of Taxol 294 
(Fig. 3i, white arrows).  295 
Next, we used fluorescence recovery after photobleaching (FRAP) assays in the tubulin channel 296 
to test for tubulin incorporation at the Fchitax-3 accumulation zones. Whereas control 297 
microtubule lattices showed no fluorescence recovery (Supplementary Fig. 7e), Fchitax-3 298 
accumulation zones displayed clear recovery of the tubulin signal (Fig. 6g). In some cases, the 299 
length of tubulin incorporation detected after photobleaching was up to ~1µm (Supplementary 300 
Fig. 7f). We also frequently observed transient binding of EB3, a marker of growing microtubule 301 
ends, within the drug accumulation areas (Fig. 6h, Supplementary Fig. 7g). These data indicate 302 
that tubulin indeed incorporates into microtubule lattice within Fchitax-3 accumulation zones. 303 
Such microtubule repair explains why the length of microtubule lattice defects observed by EM 304 
(~100nm) was much shorter than the length of Fchitax-3 accumulation zones, which could extend 305 
to several micrometers (compare Fig. 6d and Supplementary Fig. 7h). These results indicate that 306 
formation of Fchitax-3 accumulations is associated with major microtubule lattice defects such as 307 
missing parts of protofilaments that are partly restored by tubulin incorporation.  308 
  309 
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Discussion 310 
In this study, we found that the association of taxane-site ligands with microtubules preferentially 311 
occurs at growing microtubule ends and strongly depends on the conformational state of these 312 
ends, leading to a highly uneven binding pattern along the microtubule shaft. This observation 313 
helps to explain why taxane-site ligands have a stronger effect on the microtubule lattice structure 314 
when added during and not after microtubule polymerization34,39. Previous models of Taxol 315 
stabilization mechanisms assumed a stochastic but homogeneous change in the rate constants and 316 
thermodynamic states of tubulin dimers inside a microtubule40. In contrast, our data show that at 317 
non-saturating concentration of the compound, microtubule stabilization is achieved by the 318 
formation of specific zones (local “clusters”) with an increased stability, possibly due to a 319 
cooperative change in the microtubule lattice structure. The formation of local clusters is 320 
reminiscent of polymorphic transitions in crystals, suggesting that the addition of a taxane-site 321 
ligand to dynamic microtubules induces altered forms of microtubule lattices.  322 
The nucleotide state of tubulin plays a role in controlling taxane affinity for microtubules, with 323 
the GMPCPP-bound, extended conformation being preferred over the compacted GDP or GTPγS 324 
lattice, consistent with the data that both GMPCPP- and Taxol-bound microtubules have 325 
expanded lattice10,33,34. However, the pattern of ligand binding to a growing microtubule cannot 326 
be explained by the nucleotide state of tubulin alone. Our data suggest that taxane-site ligands 327 
can preferentially bind to incomplete microtubule structures present at the ends and strongly 328 
modify the properties of these structures (Fig. 6i). The increased affinity of taxanes for 329 
incomplete tubulin structures, such as tubulin sheets, can explain their binding kinetics: as long as 330 
the tube is incomplete, taxane keeps binding, but if the sheet closes into a tube, a significant 331 
proportion of the drug molecules is released. Our data are consistent with the idea that, after tube 332 
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closure and growth continuation, an open structure remains at the initial part of the drug 333 
accumulation zone, explaining why the drug can still exchange within this region and create a 334 
stable site that inhibits microtubule depolymerization. Incorporation of GTP-tubulin at the drug 335 
accumulation zones promotes their stability and their capacity to induce rescues, as described 336 
previously for other situations where microtubule lattice repair has been observed41-43. 337 
Importantly, our data suggest that microtubule repair at the drug accumulation sites is not 338 
complete – a part of the microtubule lattice remains open, but is not depolymerized due to the 339 
presence of drug molecules.  340 
An interesting feature of taxane binding to microtubule lattices is its cooperative character. Our 341 
modeling based on the kinetic binding curves suggests that initially only a few tubulin dimers 342 
within the microtubule lattice can bind the drug, and that drug association catalyzes formation of 343 
additional binding sites in the vicinity. One potential explanation of such cooperativity could be 344 
based on the propagation of an extended conformational state of the microtubule lattice, which 345 
was observed for Taxol-bound microtubules by cryo-EM10,33,34 and in our X-ray fiber diffraction 346 
experiments. A similar elongation of the axial microtubule repeat has recently been proposed to 347 
underlie the positive cooperativity in the binding of kinesin-1 to microtubules44. However, since 348 
taxane-site ligands can also affect lateral contacts between tubulin dimers13-16, it is possible that 349 
alterations in these contacts account for propagating structural effects, such as a differential 350 
curvature of tubulin sheets.  351 
Taxane-bound zones at microtubule ends represent suboptimal substrates for microtubule 352 
shrinkage but also for microtubule growth. This leads to slow growth and frequent transitions 353 
between growth and shortening, which help to explain the surprising observation that although 354 
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Taxol is a microtubule stabilizer, at low concentrations it perturbs microtubule growth in cells 355 
(reviewed in45, see22 for an example).  356 
An important conclusion of our study is that the conformational transitions at microtubule ends, 357 
which lead to growth perturbation and catastrophes also promote taxane-site ligand binding and 358 
microtubule stabilization by these compounds. One interesting consequence of this effect is that 359 
the distribution of ligand accumulations along the microtubule shaft reflects the history of the 360 
growth of this microtubule. Another important consequence is that taxane-site ligand binding to 361 
microtubules can be potentiated by low doses of catastrophe-inducing MTAs, and some evidence 362 
supporting this idea has already been reported based on cell culture experiments23. Our data 363 
provide an explanation for this phenomenon and suggest that in future work it can be exploited 364 
for optimizing MTA-based cancer therapies.  365 
  366 
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Figure legends 496 
Figure 1: Taxol and its fluorescent derivatives induce formation of stable rescue sites in 497 
microtubules.  498 
a-c) Schemes illustrate in vitro microtubule growth events observed during control conditions and 499 
in the presence of microtubule stabilizing drugs. Representative kymographs illustrate the 500 
dynamics of microtubules grown from GMPCPP seeds in the presence of 15μM tubulin and 501 
20nM mCherry-EB3 without or with Taxol, Fchitax-3 or Flutax-2 (100nM), as indicated. A 502 
stable rescue site in (a) is highlighted by a stippled white line. Note the enhanced green 503 
fluorescence of Fchitax-3 or Flutax-2 at the stable rescue site (white arrow). Bar graphs (mean ± 504 
SD) show the quantification of Fchitax-3 (n=65, N=5 independent experiments) and Flutax-2 505 
(n=45, N=3 independent experiments) intensity on GDP lattice and on stable rescue site. The 506 
values were normalized to the intensity of the GDP lattice. Error bars represent SD. ****p 507 
<0.00001, Mann–Whitney U-test. 508 
d) Frequency of the occurrence (mean ± SD) of stable rescue sites (calculated per unit of 509 
microtubule length) at the indicated compound concentrations. ND, not detected.  n = 25, 40 and 510 
25 microtubules for 50, 100 and 200nM of Fchitax-3, respectively, n = 25 microtubules for Taxol 511 
and Flutax-2 each, 3 independent experiments. Error bars represent SD.  512 
e) Still images, time-lapse images (corresponding to the white circle in the still image) and 513 
representative kymographs showing the formation of a dot-like Fchitax-3-accumualtion 514 
corresponding to a stable rescue site in a microtubule in a HeLa cell.  Bar graph (mean ± SD) 515 
shows the quantification of occurrence of stable rescue sites in HeLa cells. n=200 and 426 516 
kymographs from 20 cells each for control and Fchitax-3 (100nM) treated sample (N=4 517 
independent experiments). Error bar represent SD; ND, not detected. 518 
 519 
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Figure 2: Taxane-site binding compounds accumulate at growing microtubule ends and 520 
perturb microtubule growth and depolymerization.  521 
a-d) Kymographs, representative of 3 independent experiments, illustrating the accumulation of 522 
the indicated compounds at the microtubule plus- (a,c,d) or minus- (b) ends (white arrow in the 523 
merged panel) in the presence of 15μM tubulin and 100nM Fchitax-3 or Alexa488-Epothilone B, 524 
as indicated, with or without 20nM mCherry-EB3. In (d), 3% rhodamine-tubulin was added to the 525 
assay.  526 
e,f) Fluctuations of fluorescence intensities (mean ± SD) of mCherry-EB3 at microtubule tips 527 
over time in control assays (15µM tubulin, 20nM mCherry-EB3) or in the presence of 100nM 528 
Fchitax-3, before or during the course of Fchitax-3 accumulation. (e), intensity distributions, with 529 
the experimental data shown by solid lines, and Gaussian fits by dotted lines, n=30 for control 530 
and n=25 for Fchitax-3 treated sample, N=3 independent experiments. (f), plots of the mean and 531 
SD values of the Gaussian fits.  532 
g) Microtubule growth rate (mean ± SD) in the presence of 15µM tubulin, 20nM mCherry-EB3 533 
and 100nM Fchitax-3 before, during and after an Fchitax-3 accumulation. n=51 in each case, 534 
N=3 independent experiments, error bars represent SD; ****p<0.0001 (growth rate during 535 
accumulation was compared with the rates before and after Fchitax-3 accumulation), Mann–536 
Whitney U-test.  537 
h) Schematic representation and still images of laser ablation of a microtubule with an Fchitax-3 538 
accumulation zone, observed in the presence of 15µM tubulin (supplemented with 3% rhodamine 539 
tubulin), 20nM mCherry-EB3 and 100nM Fchitax-3. The ablated microtubule region is 540 
highlighted by a lightning bolt and white oval. The positions of the plus- and minus ends of the 541 
microtubule are indicated. Quantification (mean ± SD) of microtubule survival after the ablation 542 
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in control conditions (no drug) or within an Fchitax-3 accumulation zone (n=15 microtubules 543 
from 5 independent experiments) is shown on the right. ND = not detected.   544 
 545 
Figure 3: Formation of accumulations of taxane-site ligands is controlled by microtubule 546 
dynamics.  547 
a) Kymographs, representative of 3 independent experiments, showing Fchitax-3 accumulations 548 
in microtubules grown in the presence of the indicated tubulin concentrations, 20nM mCherry-549 
EB3 and 100nM Fchitax-3. 550 
b) Quantification of Fchitax-3 accumulation frequency (mean ± SD) for the experiments shown 551 
in (a). n = 15, 20, 40 and 37 accumulations in 250, 185, 135 and 94 growth events for 8, 10, 15 552 
and 25µM of tubulin, respectively. N=3 independent experiments, error bars represent SD, ****p 553 
<0.0001, Mann–Whitney U-test.  554 
c) Kymograph showing the initiation of an Fchitax-3 accumulation, associated with the reduction 555 
in mCherry-EB3 signal. N=5, experimental conditions as in (a).  556 
d) Time plot of the normalized maximum intensity of a fitted EB3 comet (red) and the 557 
normalized area under the curve (AUC) of a fitted Fchitax-3 (green) intensity profile. The dashed 558 
green line shows the fit of Fchitax-3 kinetics to a Hill equation (on x-axis, time was used instead 559 
of concentration), representative of 5 experiments.  560 
e) Averaged EB3 and Fchitax-3 profiles (same as in d), normalized and aligned using EC50 values 561 
from Hill equation fits as reference points (9 kymographs from 5 experiments).  562 
f,h,i,j) Kymographs (representative of 3 experiments) illustrating microtubule dynamics in the 563 
presence of 15μM tubulin and indicated compounds and proteins. Note that GFP-MCAK at 564 
growing microtubule ends and Fchitax-3 accumulations are detected in the same channel. White 565 
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arrows highlight EB3 comets emerging from the accumulation zones and moving in the reverse 566 
direction.  567 
g) Quantification of Fchitax-3 accumulation frequencies (mean ± SD) per microtubule unit length 568 
in the presence of 15μM tubulin (n=22), 20nM mCherry-EB3 (n=40), 15µM tubulin with 100nM 569 
vinblastine (n=25), 20nM mCherry-EB3 with 100nM vinblastine (n=30) and 20nM mCherry-570 
EB3 with 5nM MCAK (n=34). n represents number of microtubules, N=3 independent 571 
experiments, error bars represent SD.  572 
 573 
Figure 4: Analysis of the kinetics of Fchitax-3 accumulations.  574 
a) Kymograph, representative of 5 independent experiments, with a long Fchitax-3 accumulation 575 
(left) and a line intensity time trace of Fchitax-3 at the beginning of the accumulation (right).  576 
b) Schematic kinetic diagram of the Michaelis-Menten (top reaction) and autocatalysis (top and 577 
bottom reactions) models for Fchitax-3 binding. Three tubulin states are considered: initial 578 
[Tuunreceptive] state unable to bind Fchitax-3, Fchitax-3 binding state [Tureceptive] and final converted 579 
state [Tulattice] (again, unable to bind Fchitax-3). For more details see Methods. 580 
c) Left: best fits to a single profile shown in (a) using Michaelis-Menten (red line) or the 581 
autocatalysis model (blue line). Right: raw data, best fits and residuals of the autocatalysis model 582 
to the area of the kymograph marked with a yellow rectangle in (a). Arrows 1 and 2 indicate the 583 
positions along the microtubule, for which FRAP was modeled in (f), with white dashes 584 
indicating the moments of photobleaching used for calculating the modeled curves. 585 
d) Rate constants (mean ± SD) of kinetic autocatalysis model (b) derived from the intensity time 586 
trace fits (9 kymographs, 46 time traces total). Error bars represent SD. 587 
e) Left panel: kymograph of three sequential photobleaching events (highlighted by black 588 
arrowheads) of an Fchitax-3 accumulation. Right panel: intensity time traces along the lines 589 
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marked by arrows 1 and 2 in the kymograph. Kymograph and intensity time traces are 590 
representative of 3 independent experiments. 591 
f) Modeling of FRAP curves: solutions of the model for fluorescence recovery with parameter 592 
values from fits shown in (c) right panel, where the moments of photobleaching are indicated by 593 
white dashes. The same photobleaching moments are indicated by black arrowheads in (f).  594 
 595 
Figure 5: Analysis of the nucleotide dependence of Fchitax-3 accumulations. 596 
a) Fchitax-3 (100nM) fluorescence intensity profile on GMPCPP stabilized microtubule seed, 597 
dynamic microtubule lattice (GDP lattice) and within an Fchitax-3 accumulation. Bar graphs 598 
(mean values) show quantification of the normalized maximum value of fluorescence intensity on 599 
GMPCPP stabilized microtubule seed, GDP lattice and within an Fchitax-3 (n=50, N=5), Flutax-600 
2 (n=34, N=3) or Alexa488-Epothilone B (n=40, N=3) accumulation zone. The values were 601 
normalized to the intensity of the GDP lattice.  Error bars represent SD. ****p <0.0001, Mann–602 
Whitney U-test. 603 
b) Kymographs illustrating in vitro dynamics of a microtubule that was first grown from a 604 
GMPCPP seed in the presence of 15µM tubulin and 20nM mCherry-EB3 (1), then in the 605 
presence of 5µM tubulin supplemented with 3% rhodamine tubulin and 250µM GMPCPP 606 
(GMPCPP cap) (2) and then incubated with 100nM Fchitax-3 (3). Fluorescence intensity profiles 607 
and the Fchitax-3 intensities (mean) normalized to the intensity of the GDP lattice are shown on 608 
the right. n=20, N=3 independent experiments. Error bars represent SD, ****p <0.0001, ns = not 609 
significant, p = 0.25, Mann–Whitney U-test.  610 
c, d) Representative kymographs, single line intensity time traces and plot (mean value) showing 611 
the rate constant of photobleaching of Fchitax-3 within GMPCPP seeds. n=11, N = 5 independent 612 
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experiments. Error bar represents SD. Black arrowheads indicate the time point when 613 
photobleaching was performed. 614 
e) Representative kymographs, intensity profiles and a plot (mean) showing the quantification of 615 
the intensity of Fchitax-3 fluorescence for GMPCPP-stabilized  seed, microtubule lattice grown 616 
in the presence of 15µM tubulin, 20nM mCherry-EB3, 1mM GTPүS  and 100nM Fchitax-3 617 
(GTPүS lattice) and the Fchitax-3 accumulation zone within the same microtubule. Intensity 618 
values were normalized to the intensity of the GTPүS lattice. n=30 from N=3 independent 619 
experiments, error bars represent SD, ****p <0.0001, Mann–Whitney U-test. 620 
 621 
Figure 6: Fchitax-3 promotes long sheet-like microtubule defects and generates sites of 622 
tubulin incorporation.  623 
a,b) Cryo-EM images (representative of 2 experiments) of microtubules grown with 15µM 624 
tubulin and 20nM mCherry-EB3 without (a) or with (b) 100nM Fchitax-3. Long sheet-like 625 
defects are boxed.  626 
c,d) Quantification of percentage of total defects (c) and defects with certain length (d) in 627 
GMPCPP stabilized microtubules, control (-Fchitax-3) (n=311 microtubules) and Fchitax-3 628 
treated microtubules (+Fchitax-3) (n=833 microtubules), combined from 2 experiments each. 629 
****p <0.0001; ns, no statistically significant difference, p=0.2, Pearson’s chi-square test.  630 
e) Top: time-lapse images illustrating that Fchitax-3 accumulation is accompanied by 631 
microtubule bending. Bottom left, an example of transverse microtubule tip fluctuations; bottom 632 
right, average standard deviation (normalized to the values before Fchitax-3 accumulation) of the 633 
microtubule tip fluctuations before, during and after an Fchitax-3 accumulation. n=11, N=5,  634 
**p=0.0038; ns, no statistically significant difference, p=0.55, Mann–Whitney U-test.  635 
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f) Left: kymographs illustrating microtubule dynamics with 15µM tubulin, 20nM GFP-EB3, 636 
100nM Fchitax-3 and 10nM mCherry-CAMSAP3. Middle: a scheme illustrating CAMSAP3 637 
binding to a microtubule minus end and protofilaments extending from an Fchitax-3 638 
accumulation in the minus-end direction. Right: fluorescence intensity profiles and 639 
quantifications (mean ± SD) showing CAMSAP3 intensity at the microtubule regions grown 640 
from the minus (1) and plus (2) end of the seed and Fchitax-3 accumulation (3). Data were 641 
normalized to the CAMSAP3 intensity of the microtubule grown from the minus end (2). n=10, 642 
N=3 independent experiments.  643 
g) Left: kymographs showing FRAP within microtubule region with Fchitax-3 accumulation. 644 
White lightning bolt highlights the bleached region, and white arrowheads highlights tubulin 645 
fluorescence recovery within bleached area. Middle: fluorescence intensity profiles of unbleached 646 
and bleached microtubule regions with and without Fchitax-3 accumulation. Right: quantification 647 
(mean ± SD) of tubulin fluorescence before, during and after photobleaching in control 648 
microtubules (n=14) and microtubule regions with an Fchitax-3 accumulation (n=15), N=3 649 
independent experiments. ****p <0.0001, , *p=0.1, Mann–Whitney U-test. 650 
h) Quantification (mean ± SD) of EB3 fluorescence at growing plus ends or within microtubule 651 
regions with or without an Fchitax-3 accumulation (n=30 microtubules from N=3 independent 652 
experiments). Intensity values were normalized to the intensity of EB3 at growing microtubule 653 
plus ends.****p <0.0001, Mann–Whitney U-test.  654 
i)   A model showing interaction of taxane-site ligands with microtubules. Taxanes show 655 
preference for GMPCPP- over GDP-bound microtubule lattice. The onset of catastrophe 656 
promotes taxane binding possibly due to end tapering and appearance of tubulin sheets. The 657 
drugs exhibit binding cooperativity and stabilize these microtubule structures. Subsequently, the 658 
regular microtubule structure is re-established due to tubulin incorporation; however, remnants of 659 
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an incomplete microtubule structure with a high drug affinity remain; they stabilize the site, 660 
incorporate GTP-tubulin and promote repeated rescues. 661 
  662 
 38 
 
Methods 663 
Reagents and purified proteins 664 
Taxol was purchased from Enzo Life Sciences. Vinblastine sulfate, GTP (Guanosine 665 
triphosphate), Glucose Oxidase from Aspergillus niger, Catalase from bovine liver, 666 
Methylcellulose, DTT (Dithiothreitol), PIPES (1,4-Piperazinediethanesulfonic acid, Piperazine-667 
1,4-bis(2-ethanesulfonic acid), Piperazine-N,N′-bis(2-ethanesulfonic acid)), Magnesium 668 
chloride, EGTA (Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid), 669 
Potassium hydroxide, Potassium chloride, κ-casein, Glucose, Fetal bovine serum, Penicillin-670 
Streptomycin antibiotic were from Sigma-Aldrich. GMPCPP (Guanosine-5'-[(α,β)-671 
methyleno]triphosphate, Sodium salt) was from Jena Biosciences. PLL-PEG-biotin (Biotinylated 672 
poly(L-lysine)-[g]-poly(ethylene glycol) was from Susos AG, Switzerland. NeutrAvidin was 673 
from Invitrogen. DMEM and F10 media, LT07-518 Mycoalert assay were from Lonza, Basel, 674 
Switzerland. Trysin-EDTA was from Biowest. FuGENE 6 was from Roche, Switzerland. 675 
Different types of labelled and unlabelled purified tubulin used in the assays were from 676 
Cytoskeleton, Denver, USA or purified as described previously46 for fibre diffraction 677 
experiments. mCherry-CAMSAP3 and GFP-MCAK were purified as described previously38, 47.  678 
 679 
Synthesis of Alexa488-Epothilone B 680 
Alexa488-Epothilone B was prepared by click reaction between an alkyne group-containing, C-6 681 
modified epothilone B analog and an azide-containing derivative of Alexa 488. Alexa FluorTM 682 
488 Azide (2.18mg, 2.53µmol, 1.00eq) and C-6 modified epothilone B analog GS-240 (1.45mg, 683 
2.53µmol, 1.00eq) were suspended in a mixture of tBuOH and water (1:1, 0.20ml). To this 684 
suspension Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amin (0.40mg, 0.758µmol, 0.30eq.) was 685 
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added and freshly prepared aqueous sodium ascorbate solution (1M solution in water,  2.5μl, 686 
2.53µmol, 1.00eq) followed by an aqueous copper sulfate pentahydrate solution (0.8M, 0.6μl, 687 
0.505µmol. 0.2eq). The reaction mixture was stirred for 4h at room temperature, until HPLC 688 
control showed complete conversion. The solvents were then removed under reduced pressure 689 
and the resulting residue was dissolved in a mixture of MeCN and water (1:2, 0.4ml) until a clear 690 
solution had formed. This solution was then directly purified by preparative HPLC 691 
(SymmetryPrepTM C18, 5µm, 19x100mm; MeCN: water 0:100 to MeCN: water 100:0 over 15 692 
min, Retention time: 9.1min). Lyophilisation gave the compound Alexa488-Epothilone B as a pink 693 
solid (2.71mg, 2.20µmol, 87%). 694 
 695 
In vitro assay for microtubule dynamics 696 
In vitro assay for microtubule growth dynamics was performed as described previously29. Briefly, 697 
as described earlier48, GMPCPP stabilized microtubule seeds were prepared by two cycles of 698 
microtubule polymerization and depolymerization in the presence of GMPCPP (a slowly 699 
hydrolyzable GTP analog). A solution of porcine brain tubulin (20µM) mix containing biotin 700 
labeled-tubulin (18%) and rhodamine labeled-tubulin (12%) was polymerized in MRB80 buffer 701 
(80mM K-PIPES, pH 6.8, 4mM MgCl2, 1mM EGTA) in the presence of GMPCPP (1mM) at 702 
37°C for 30min. After polymerization, the mixture was pelleted by centrifugation in an Airfuge 703 
for 5min at 119,000 ×g. Obtained pellet was re-suspending in MRB80 buffer, depolymerized on 704 
ice for 20min and further polymerized in the presence of GMPCPP. After the second round of 705 
polymerization and pelleting, GMPCPP-stabilized microtubule seeds were stored in MRB80 706 
containing 10% glycerol. In vitro flow chambers for TIRF microscopy were assembled on 707 
microscopic slides by two strips of double-sided tape with plasma-cleaned glass coverslips. Flow 708 
chambers were sequentially incubated with 0.2mg/ml PLL-PEG-biotin and 1mg/ml NeutrAvidin 709 
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in MRB80 buffer. Flow chambers were further incubated with GMPCPP stabilized microtubule 710 
seeds followed by treatment with 1mg/ml κ-casein. The reaction mixtures (15μM porcine brain 711 
tubulin supplemented with 3% rhodamine-tubulin when indicated, 20nM mCherry-EB3 or GFP-712 
EB3 when indicated, 50mM KCl, 1mM guanosine triphosphate, 0.1% methylcellulose, 0.2mg/ml 713 
κ-casein and oxygen scavenger mixture (50mM glucose, 400μg/ml glucose oxidase, 200μg/ml 714 
catalase, and 4mM DTT in MRB80 buffer) with or without MTAs, GFP-MCAK or mCherry-715 
CAMSAP3 were added to the flow chambers after centrifugation in an Airfuge for 5min at 716 
119,000 ×g. Flow chambers were sealed with vacuum grease, and microtubule dynamics was 717 
recorded using TIRF microscopy. During in vitro sample imaging all samples were maintained at 718 
30°C, cells were imaged at  37°C.  719 
 720 
Cell culture 721 
HeLa and HEK293T cells, obtained from ATCC, were cultured in DMEM/Ham’s F10 media (1:1 722 
ratio) supplemented with 10% fetal calf serum and 1% antibiotics (penicillin and streptomycin). 723 
ATCC performs short-tandem repeat profiling for cell line authentication, and no additional cell 724 
line authentication was performed. The cell line used here was not found in the database of 725 
commonly misidentified cell lines maintained by ICLAC. The cell line was routinely checked for 726 
mycoplasma contamination using LT07-518 Mycoalert assay. To determine the cellular effects of 727 
Fchitax-3, HeLa cells, transiently transfected with EB3-TagRFP (Grigoriev et al., 2008) using 728 
FuGENE 6, were treated with 100nM Fchitax-3 for 1hour. Cell imaging was performed using 729 
TIRF microscopy. 730 
 731 
Image acquisition by TIRF microscopy and image analysis 732 
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Imaging was performed on a TIRF microscope setup (inverted research microscope Nikon 733 
Eclipse Ti-E) which was equipped with the perfect focus system (PFS) (Nikon) and Nikon CFI 734 
Apo TIRF 100x 1.49 N.A. oil objective (Nikon, Tokyo, Japan). The microscope was 735 
supplemented with TIRF-E motorized TIRF illuminator modified by Roper Scientific 736 
France/PICT-IBiSA Institut Curie, and a stage top incubator model INUBG2E-ZILCS (Tokai 737 
Hit) was used to regulate the temperature of the sample. Image acquisition was performed using 738 
either a Photometrics Evolve 512 EMCCD camera (Roper Scientific) or a Photometrics 739 
CoolSNAP HQ2 CCD camera (Roper Scientific) and controlled with MetaMorph 7.7 software 740 
(Molecular Devices, CA). For simultaneous imaging of red and green fluorescence we used 741 
triple-band TIRF polychroic ZT405/488/561rpc (Chroma) and triple-band laser emission filter 742 
ZET405/488/561m (Chroma), mounted in the metal cube (Chroma, 91032) together with 743 
Optosplit III beamsplitter (Cairn Research Ltd, Faversham, UK) equipped with double emission 744 
filter cube configured with ET525/50m, ET630/75m and T585LPXR (Chroma). Measurement of 745 
491 nm laser power under TIRF conditions was performed using ThorLabs optical power and 746 
energy meter (PM400) unit using S170C sensor. Under TIRF conditions, maximum laser 747 
intensity (100% laser power) for 491 nm laser was found to be 160μW. 748 
ImageJ plugin KymoResliceWide v.0.4 (https://github.com/ekatrukha/KymoResliceWide 749 
(Katrukha, 2015)) was used for generating kymographs to represent the life history of 750 
microtubule dynamics. As described previously21,29, microtubule dynamics parameters from 751 
kymographs were determined with an optimized version of the custom-made JAVA plugin for 752 
ImageJ. For catastrophe frequency quantification, short depolymerization events (as depicted in 753 
Supplementary Fig. 4a, white arrow) were also considered as a catastrophe event.  754 
 755 
Single molecule intensity analysis 756 
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To estimate the fluorescence intensity of single molecules of Fchitax-3, two parallel flow 757 
chambers were made on the same coverslip. In one chamber, regular microtubule dynamic assay 758 
in the presence of GMPCPP stabilized microtubule seeds with tubulin, mCherry-EB3 and 759 
Fchitax-3 was performed. The other chamber was incubated with the same concentration of 760 
Fchitax-3 without the reaction mixture. In both conditions, the first 10-20 images of unexposed 761 
coverslip areas were acquired with the 100ms exposure time using low laser intensity and then a 762 
movie of 10-20 frames exposing the same area with continuous laser illumination was recorded 763 
to induce photobleaching of Fchitax-3 molecules. Fluorescence intensities of Fchitax-3 molecules 764 
binding to the coverslip in both chambers were detected and measured using ImageJ plugin 765 
DoM_Utrecht v.0.9.1 (https://github.com/ekatrukha/DoM_Utrecht). The fitted peak intensity 766 
values were used to build fluorescence intensity histograms, which were compared to the 767 
intensity of Fchitax-3 signal on microtubules. The histograms were fitted to Gaussian  768 
distributions using GraphPad Prism 7. 769 
 770 
Analysis of EB3 intensity fluctuations at the microtubule plus end  771 
The distributions of EB3 intensities (normalized to the maximum value) were analyzed during the 772 
course of a growth event in control conditions (15µM tubulin, 20nM EB3) or with the addition of 773 
100nM Fchitax-3. In case of Fchitax-3, fluctuations of EB3 intensity were analyzed before the 774 
initiation of Fchitax-3 accumulation and during the course of Fchitax-3 accumulations. For 775 
control measurements, we excluded the EB3 signal during the last phase of growth before 776 
catastrophe (pre-catastrophe phase) from our analysis as at this point the comet intensity is 777 
reduced21, 49.  778 
 779 
Laser ablation of microtubules in vitro 780 
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Laser photoablation assay in which an individual microtubule is severed by a focused laser beam 781 
was performed on the TIRF microscope equipped with an ILas system (Roper Scientific 782 
France/PICT-IBiSA) and a 532nm Q-switched pulsed laser (Teem Photonics). In vitro 783 
microtubule dynamics assay was performed in the presence of GMPCPP stabilized microtubule 784 
seeds with 15µM tubulin supplemented with 3% rhodamine-tubulin, 20nM mCherry-EB3 785 
without or with 100nM Fchitax-3.  786 
 787 
Fluorescence recovery after photobleaching (FRAP) assay 788 
FRAP assay in which a region of a microtubule is bleached by a focused laser beam was carried 789 
on the TIRF microscope equipped with an ILas system (Roper Scientific France/PICT-IBiSA). In 790 
vitro microtubule dynamics assay was performed in the presence of GMPCPP stabilized 791 
microtubule seeds with 15µM tubulin supplemented with 3% rhodamine-tubulin without 792 
(control) or with 100nM Fchitax-3. Photobleaching in the tubulin channel was performed with 793 
the 561nm laser. In case of control, a segment of GDP microtubule lattice was photobleached. In 794 
case of Fchitax-3 containing samples, photobleaching was performed in the microtubule segment 795 
with Fchitax-3 accumulation zone. 796 
 797 
X-Ray fiber diffraction experiments 798 
X-Ray fiber diffraction images were collected in beamline BL11-NCD-SWEET of ALBA 799 
Synchrotron. Purified bovine tubulin was diluted to a final concentration of 100µM of PEM 800 
buffer (80mM PIPES, 1mM EGTA, 0.2mM Tris, 1mM DTT, 3mM MgCl2). GDP-tubulin was 801 
obtained from diluted tubulin by hydrolysis, by incubating diluted protein for 30min at 37ºC and 802 
then supplementing the samples with 1mM GDP. GTP-tubulin was obtained by supplementing 803 
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the dilution buffer with 2mM GTP. Microtubules were obtained incubating tubulin samples for 804 
30min at 37ºC to achieve maximum polymerization. 200µM Taxol was added to the samples 805 
either before microtubule polymerization (pre-assembly assays) or after polymerization (post-806 
assembly assays). The samples were then mixed at 1:1 volume ratio with pre-warmed PEM 807 
buffer containing 2% Methylcellulose (MO512, Sigma-Aldrich). Final concentrations of protein, 808 
nucleotide and compounds were 50µM tubulin, 100µM Taxol and 1mM GTP or 1mM GDP. 809 
Samples were centrifuged 10s at 2000g to eliminate air bubbles and transferred to a share flow 810 
device50, 51. 811 
For each condition, a total 24 of diffraction images were averaged and background subtracted 812 
using ImageJ software (version 1.51j8; Wayne Rasband, National Institutes of Health, Bethesda, 813 
USA). Angular image integrations were performed using XRTools software (obtained from 814 
beamline BM26-DUBBLE of the European Synchrotron Radiation Facility (ESRF)). For average 815 
monomer length determination, 4th harmonic of the first layer line signals (1nm peak, 4th layer 816 
line) was fitted to a single-peaked Lorentzian function using Sigma-Plot software (Version 12.0) 817 
using peak maxima distance to center to calculate average monomer length. 818 
 819 
Averaging of EB3 and Fchitax-3 intensity time traces 820 
Simultaneous two color imaging of Fchitax-3/mCherry-EB3 was performed using an OptoSplit 821 
III beamsplitter (Cairn Research Ltd, UK) equipped with double emission filter cube projecting 822 
two channels on the camera chip simultaneously. Cromatic aberrations were corrected as 823 
described previously using calibration photomask47. Registered videos were used to create 824 
kymographs by drawing segmented lines of 10 pixel width (0.65μm) along growing microtubules 825 
using KymoResliceWide plugin with maximum transverse intensity 826 
(http://fiji.sc/KymoResliceWide). On extracted kymographs, we outlined rectangular ROI around 827 
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observed accumulation event and exported both intensities. For each frame, we fitted mCherry-828 
EB3 profile with sum of constant (lattice binding) and exponential decay functions (comet) 829 
convoluted with microscope’s PSF: 830 
ܫ(ݔ, ݐ) = ܫ஻ீ +
1
2 ܫ௟௔௧௧௜௖௘ ∙ erfc ൬
ݔ − ݔ௖
√2ߪ ൰ + 
                                  +ଵଶ ܫ௣௘௔௞ ∙ exp ൬
ఒ
ଶ ൫ߪଶߣ + 2(ݔ − ݔ௖)൯൰ ∙ ቆ1 − erf ቀ
ఙమఒା௫ି௫೎
√ଶఙ ቁቇ                    (1)                         831 
where fitting parameter IBG corresponds to the intensity of background, Ilattice to the amplitude of 832 
the fluorescent intensity fraction associated with the lattice binding, Ipeak to the amplitude of 833 
convolved exponential decay, xc to the position of the maximum number of molecules in the 834 
molecules distribution (start of exponential decay position), σ to the PSF standard deviation and λ 835 
to the exponential decay constant. From the fitted function I(x,t) at each time frame t we obtained 836 
maximum fluorescent intensity IEB3(t) = maxx I(x,t). 837 
Intensity of Fchitax-3 was fitted with Gaussian function with background, where the width was a 838 
fitting parameter. Total intensity was calculated as an integrated area under the fitted curve 839 
(without background intensity) and provided IFchitax-3(t). This function for each kymograph was 840 
further fitted with dose-response Hill equation, substituting the concentration for time: 841 
                                                   ܫி௖௛௜௧௔௫ିଷ(ݐ) = ܫ஻ீ + ூಾೌೣିூಳಸଵାቀഓఱబ%೟ ቁ
೓                                                  (2) 842 
where fitting parameter IBG corresponds to the background fluorescence, IMax is maximum 843 
intensity of Fchitax-3, h is a Hill coefficient and τ50% corresponds to the time when intensity 844 
reaches half of its value. The choice of Hill equation was just a matter of convenience, other 845 
sigmoid-like functions (for example, error function) worked equally well. All IEB3(t) and IFchitax-846 
3(t) intensity traces were normalized by the minimum and maximum values and shifted in a way 847 
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that τ50% moments were aligned (making this point t=0). For the averaging at the same time-848 
sampling moments intensity profiles were linearly interpolated with the step of 0.1 of a frame. 849 
 850 
Analysis of microtubule fluctuations 851 
To estimate the transversal fluctuations of the microtubule tip, before, during and after the 852 
Fchitax-3 accumulation, we first determined the position of the microtubule tip. The tracking of 853 
microtubule plus-ends was performed using Trackmate plugin in Fiji (http://fiji.sc/TrackMate)52. 854 
Post-processing of the tracks was carried out by a custom made script in MATLAB. For each 855 
growth event, the tracking provided coordinates x(ti) and y(ti) of the fluorescent peak of an EB3 856 
comet in the plane of the coverslip over time points ],...,1[, Niti ∈ . The trajectory of the comet 857 
was fit with a straight line y mx c= +  (forced to pass through xS and yS) to find the average axis 858 
of microtubule growth. To split the movement of the microtubule end into longitudinal xr(t) and 859 
transverse yr(t) components, we moved the origin of coordinates to the plus-end of the 860 
microtubule seed and rotated the xy plane to align the microtubule growth axis with the x-axis 861 
using the transform:  862 
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where the value of rotation angle θ  is equal to )arctan( m . The characteristic standard deviation 864 
of the transverse deflection was calculated as 865 
                                                    		ߪ௬ = ට ଵேିଵ	∑ (ݕ௥(ݐ௜) − ݕ௥ഥ )ே௜ୀଵ                                                (4)   866 
where ݕ௥ is the average deflection per track. 867 
 868 
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Cryo-EM  869 
For sample preparation, microtubules were polymerized from GMPCPP seeds with 1mM GTP, 870 
15μM Tubulin, 20nM mCherry-EB3 and in the absence or presence of 100nM Fchitax-3 at 37℃ 871 
for 10min (designated -Fchitax-3 and +Fchitax-3 sample respectively). 4μl of each sample was 872 
applied to holey carbon grids (C-flat 2/2, Protochips) glow-discharged in air, before blotting and 873 
plunge-freezing using Vitrobot Mark IV (Thermo Fisher Scientific) at 22℃ and 100% humidity. 874 
All cryo-EM micrographs were collected using a Tecnai T12 transmission electron microscope 875 
(Thermo Fisher) with a 4*4K CCD camera (Gatan) at 120kV, magnification of 52000, image 876 
pixel size of 2.09Å and defocus around -5μm. 877 
For microtubule defect analysis, images from the -Fchitax-3  and +Fchitax-3 datasets collected by 878 
one team member were randomly mixed and were scored blindly by another team member for the 879 
presence/absence of small lattice defects (< ~40nm) and larger, sheet-like lattice defects (> 880 
~40nm). Only microtubules that were longer than half a frame width and were not squashed by 881 
adjacent microtubules were included in the analysis. Following scoring, the frequency data were 882 
regrouped according to polymerization condition and differences between ±Fchitax-3 883 
microtubules were evaluated for statistical significance using Pearson’s chi-square test using 884 
GraphPad Prism 7. 885 
 886 
Statistical analysis 887 
All the histograms were plotted in GraphPad Prism 7, and statistical analysis was done using non-888 
parametric Mann-Whitney U-test. For figure 6c, one sided Pearson’s chi-square test was 889 
performed. All reported experiments were performed 2 or more times independently. 890 
 891 
Kinetic model of Fchitax-3 accumulation 892 
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To understand how the observed dynamics of Fchitax-3 accumulation can emerge from the 893 
underlying molecular interactions, we generated a set of kinetic models based on our imaging 894 
data. Comparison of models with experimental data allowed us to eliminate contradicting 895 
mechanisms and narrow down the set to a single model presented at Fig. 4B. Below, we describe 896 
considered models and their underlying assumptions.  897 
First of all, Fchitax-3 does not bind to microtubule lattice continuously, and its accumulation 898 
occurs only at specific moments during microtubule growth. Therefore, we assumed that at some 899 
time point, a special tubulin state [Tureceptive] becomes accessible at the tip of a growing 900 
microtubule. This tubulin state can bind Fchitax-3 molecules leading to formation of 901 
[Tureceptive·Fchitax3] complex, observed in experiments. Since after the initial accumulation the 902 
intensity of Fchitax-3 at microtubule irreversibly decline (Fig. 4a), we postulated that there is a 903 
transition from Fchitax-3 bound tubulin state to another state [Tulattice], that is unable to bind 904 
Fchitax-3 (accompanied by release of Fchitax-3). This transition can be attributed to the overall 905 
structural rearrangement of microtubule lattice. The described kinetic scheme is equivalent to the 906 
Michaelis-Menten model53 (denoted here M1), where tubulin is considered as a substrate and 907 
Fchitax-3 as an enzyme. Assuming Fchitax-3 concentration in solution remains constant, the 908 
corresponding kinetic equations are: 909 
 910 
ௗ௫(௧)
ௗ௧ = −݇ଵ[Fchitax3]ݔ + ݇ିଵݕ, (M1.1)        (5) 911 
ௗ௬(௧)
ௗ௧ = ݇ଵ[Fchitax3]ݔ − ݇ିଵݕ − ݇ଷݕ, (M1.2)        (6) 912 
ݔ(0) = ൣTu୰ୣୡୣ୮୲୧୴ୣ൧଴,		ݕ(0) = 0;		 913 
ݔ(ݐ) = ൣTu୰ୣୡୣ୮୲୧୴ୣ൧(ݐ), ݕ(ݐ) = ൣTu୰ୣୡୣ୮୲୧୴ୣ ∙ Fchitax3൧(ݐ).	  (M1.3)        (7) 914 
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where x(t) corresponds to the concentration of [Tureceptive] tubulin state, y(t) to its complex with 915 
Fchitax-3 [Tureceptive·Fchitax-3], k1 and k-1 are rate constants of Fchitax-3 binding and unbinding 916 
and k3 is the rate constant of transition to [Tulattice] state. We assumed that at the initial moment, 917 
there is no [Tureceptive·Fchitax-3] complex present and there is some fixed number of [Tureceptive] 918 
binding sites.  919 
To fit model (M1.1-3) to experimental data, we built a kymograph of accumulation using 920 
KymoResliceWide plugin v.0.5 for Fiji [https://github.com/ekatrukha/KymoResliceWide] using 921 
the “maximum intensity transverse to line” option. We subtracted background intensity from the 922 
kymograph of Fchitax-3 and normalized it by maximum intensity value (after background 923 
subtraction). In this way, the maximum number of Fchitax-3 molecules per pixel over the whole 924 
duration of accumulation is equal to one. We built Fchitax-3 intensity traces over time at each 925 
pixel position along microtubule zones with Fchitax-3 accumulation. To estimate the initial 926 
moment of accumulation at specific position along the microtubule, we fitted the initial phase of 927 
Fchitax-3 increasing intensity with dose-response Hill equation, substituting the concentration for 928 
time: 929 
                                                        	ܫி௖௛௜௧௔௫ଷ(ݐ) = ܫ஻ீ + ூಾೌೣିூಳಸଵାቀഓఱబ%೟ ቁ
೓                                              (8) 930 
where fitting parameter IBG corresponds to the background fluorescence, IMax is maximum 931 
intensity of Fchitax-3, h is a Hill coefficient and τ50% corresponds to the time when the intensity 932 
reaches half of its value. The choice of the Hill equation was just a matter of convenience, other 933 
sigmoid-like functions (for example, error function) worked equally well. The fitting was 934 
performed in MATLAB (2011b, The MathWorks, Inc, MA, USA). We estimated the initial 935 
moment of accumulation as τ3%:  936 
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	߬ଷ% = ߬ହ଴% ቀ ଷ%ଵ଴଴%ିଷ%ቁ
ଵ/௛
                                               (9) 937 
Choosing any other value between 1% or 3% didn’t change the outcome of the analysis. At each 938 
pixel of accumulation along a microtubule, the normalized Fchitax-3 intensity from the moment 939 
of τ3% until the end of the acquisition was used as an input to fit a kinetic model. Analytical 940 
solution of the model (M1.1-3) was found using Mathematica v.11.0.1.0 (Wolfram Research, 941 
Champaign, IL, USA). The derived function y(t), i.e. the solution of M1.2 and M1.3 was fitted to 942 
the Fchitax-3 intensity time trace with NonlinearModelFit function using rate constants and 943 
initial concentration values as fitting parameters.  944 
 945 
The final best fit of Michaelis-Menten model (see Fig. 4c for a representative example) did not 946 
provide a satisfying description of the shape of the kinetic curve. This discrepancy can be 947 
attributed to the fact that simple binding-unbinding kinetics (M1.1) cannot produce the observed 948 
rapid increase in the accumulation of Fchitax-3 and required the addition of a non-linearity. To 949 
overcome this, we introduced a simple autocatalysis/cooperativity step, where the presence of 950 
[Tureceptive·Fchitax-3] complex increases the probability of Fchitax-3 binding to [Tureceptive] tubulin 951 
(see Supplementary Fig. 5B). Modified kinetic equations are:     952 
  953 
ௗ௫(௧)
ௗ௧ = −݇ଵ[Fchitax3]ݔ + ݇ିଵݕ − ݇ଶݔݕ, (M2.1)      (10) 954 
ௗ௬(௧)
ௗ௧ = ݇ଵ[Fchitax3]ݔ − ݇ିଵݕ + ݇ଶݔݕ − ݇ଷݕ, (M2.2)      (11) 955 
ݔ(0) = ൣTu୰ୣୡୣ୮୲୧୴ୣ൧଴,		ݕ(0) = 0;		 956 
ݔ(ݐ) = ൣTu୰ୣୡୣ୮୲୧୴ୣ൧(ݐ), ݕ(ݐ) = ൣTu୰ୣୡୣ୮୲୧୴ୣ ∙ Fchitax3൧(ݐ).	  (M2.3)      (12) 957 
 958 
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where k2 corresponds to the rate constant of the autocatalysis. Since this system of differential 959 
equations (M2.1-3) cannot be solved analytically, it was solved numerically, using 960 
ParametricNDSolveValue function of Mathematica. The same function and workflow were also 961 
used for the other non-linear models described below in this section. Residuals between the 962 
solution and experimental data were minimized using NonlinearModelFit function with 963 
Levenberg-Marquardt optimizer. Due to physical constrains on parameters values (i.e. rate 964 
constants values should be always positive), the optimizer not always converged to a true 965 
minimum in the parameter space, sometimes stalling at the borders. In this case, the relative 966 
fitting errors of parameters exceeded 100%. For such fits another set of initial parameters for the 967 
optimizer was chosen. If the minimum was still not found, the fit was discarded.  968 
 969 
The model 2 (M2) provided much better fit to the experimentally observed kinetic curve 970 
(Supplementary Fig. 5c,e) confirming that the addition of an autocatalysis step is necessary to 971 
explain the experimental data. However, this model yielded values of dissociation constant k-1 in 972 
the range of 0.2 - 0.5s-1, one order of magnitude higher than the values estimated from FRAP 973 
experiments (Fig. 5d). Simulated FRAP experiments show that Fchitax-3 recovery is almost 974 
immediate, contradicting experimental data (Fig. 4e and Supplementary Fig. 5f ). This can be 975 
explained by the fact that the dissociation rate in this case has to compensate for the much faster 976 
Fchitax-3 association, which is self-accelerated due to autocatalysis. Therefore, we excluded this 977 
kinetic mechanism.  978 
 979 
In both models described above, it was assumed that an Fchitax-3 accumulation starts with a 980 
sudden appearance of substantial amount of [Tureceptive] tubulin state (GMPCPP-like) at the tip of 981 
growing microtubule (Supplementary Fig. 5e). Instantaneous emergence of such structure seemed 982 
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implausible. Therefore, we considered an alternative scenario, where the majority of tubulin 983 
molecules exist in some initial state [Tuunreceptive] that is unable to bind Fchitax-3. If a small 984 
number of [Tureceptive] tubulins appears, this leads to [Tureceptive·Fchitax-3] complex formation that 985 
can catalyze the transition of additional [Tuunreceptive] tubulin molecules to the [Tureceptive] state. 986 
The corresponding kinetic equations are: 987 
 988 
ௗ௫(௧)
ௗ௧ = −݇ଵ[Fchitax3]ݔ + ݇ିଵݕ, (M3.1)      (13) 989 
ௗ௬(௧)
ௗ௧ = ݇ଵ[Fchitax3]ݔ − ݇ିଵݕ + ݇ଶݖݕ − ݇ଷݕ, (M3.2)      (14) 990 
ௗ௭(௧)
ௗ௧ = −݇ଶݖݕ, (M3.3)      (15) 991 
ݔ(0) = ൣTu୰ୣୡୣ୮୲୧୴ୣ൧଴; 		ݕ(0) = 0; 		ݖ(0) = ൣTu୳୬୰ୣୡୣ୮୲୧୴ୣ൧଴,		 
						ݔ(ݐ) = ൣTu୰ୣୡୣ୮୲୧୴ୣ൧(ݐ), ݕ(ݐ) = ൣTu୰ୣୡୣ୮୲୧୴ୣ ∙ Fchitax3൧(ݐ), ݖ(ݐ) = ൣTu୳୬୰ୣୡୣ୮୲୧୴ୣ൧(ݐ).				(M3.4) (16) 992 
where  z(t) corresponds to the concentration of [Tuunreceptive] tubulin state and k2 is the rate 993 
constant of autocatalysis. The numerical solution of the (M3.1-4) model is highly unstable, but 994 
nevertheless the best obtained fits provided poor description of experimental data (Supplementary 995 
Fig. 5c). In addition, the values of dissociation constant k-1 were in the same range as in model 996 
(M2.1-3), contradicting our FRAP data.  997 
 998 
After considering different kinetic schemes, we found that a model where the Fchitax-3 binding 999 
to [Tureceptive] itself catalyzes transformation of another (possibly neighboring) [Tuunreceptive] to 1000 
[Tureceptive] state, describes experimental data best. The corresponding system of kinetic equations 1001 
is: 1002 
 1003 
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ௗ௫(௧)
ௗ௧ = −݇ଵ[Fchitax3]ݔ + ݇ିଵݕ, (M4.1)      (17) 1004 
ௗ௬(௧)
ௗ௧ = ݇ଵ[Fchitax3]ݔ − ݇ିଵݕ + ݇ଶݖݔ − ݇ଷݕ, (M4.2)      (18) 1005 
ௗ௭(௧)
ௗ௧ = −݇ଶݖݔ, (M4.3)      (19) 1006 
ݔ(0) = ൣTu୰ୣୡୣ୮୲୧୴ୣ൧଴; 		ݕ(0) = 0; 		ݖ(0) = ൣTu୳୬୰ୣୡୣ୮୲୧୴ୣ൧଴,		 
ݔ(ݐ) = ൣTu୰ୣୡୣ୮୲୧୴ୣ൧(ݐ), ݕ(ݐ) = ൣTu୰ୣୡୣ୮୲୧୴ୣ ∙ ܨܿℎ݅ݐܽݔ3൧(ݐ), ݖ(ݐ) = ൣTu୳୬୰ୣୡୣ୮୲୧୴ୣ൧(ݐ).	  (M4.4) 1007 
                                                                                                                                                      (20) 1008 
 1009 
The final best fits of the model (M4.1-4) together with FRAP simulations are presented at Fig. 1010 
4c,f. The solutions for kinetics of [Tuunreceptive], [Tureceptive] and [Tureceptive ·Fchitax-3] for a 1011 
representative fit are shown at Supplementary Fig. 5g. To calculate kinetics of FRAP, first we 1012 
solved equations (M4.1-4) till the moment of bleaching tFRAP.  After that, we considered the 1013 
following system: 1014 
 1015 
ௗ௫෤(௧)
ௗ௧ = −݇ଵ[Fchitax3]ݔ෤ + ݇ିଵݕ෤ + ݇ିଵݕ௕௟௘௔௖௛௘ௗ, (M4F.1)    (21) 1016 
ௗ௬෤(௧)
ௗ௧ = ݇ଵ[Fchitax3]ݔ෤ − ݇ିଵݕ෤ + ݇ଶ̃ݖݔ෤ − ݇ଷݕ෤, (M4F.2)    (22) 1017 
ௗ௭෤(௧)
ௗ௧ = −݇ଶ̃ݖݔ෤, (M4F.3)    (23) 1018 
ௗ௬್೗೐ೌ೎೓೐೏(௧)
ௗ௧ = −݇ିଵݕ௕௟௘௔௖௛௘ௗ − ݇ଷݕ௕௟௘௔௖௛௘ௗ, (M4F.4)    (24) 1019 
ݔ෤(0) = ݔ(ݐிோ஺௉);		ݕ௕௟௘௔௖௛௘ௗ(0) = ݕ(ݐிோ஺௉); 		ݖ෥ (0) = ݖ(ݐிோ஺௉);		ݕ෤(0) = 0;	         (M4F.5)    (25) 1020 
where ybleached(t) corresponds to the concentration of the photobleached molecules of [Tureceptive 1021 
·Fchitax-3]  complex after the time tFRAP and ݕ෤(ݐ) are the newly absorbed molecules. 1022 
 1023 
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For the long accumulation event presented at Fig. 4a we explored the dependence of model 1024 
parameters on the position along an accumulation. Rate constants k1, k-1 and k3 slightly fluctuated 1025 
around their average values and didn’t show any significant trends. In contrast, the initial 1026 
concentrations of [Tuunreceptive] and [Tuunreceptive] monotonically declined from the position at the 1027 
beginning of accumulation towards its end (Supplementary Fig. 5d). This means that the size of 1028 
structure on the microtubule lattice that interacts with Fchitax-3 is gradually decreasing, which 1029 
might be attributed to the structural “closure” of microtubule lattice. 1030 
 1031 
Data availability 1032 
All data that support the conclusions are available from the authors on request. 1033 
Code availability 1034 
All MATLAB and Mathematica notebooks used for computations, together with the raw data are 1035 
available online [https://doi.org/10.6084/m9.figshare.7520033] and 1036 
https://github.com/RuddiRodriguez/Analysis-of-MT-plus-end-fluctuations 1037 
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Supplementary Figure 1: Fluorescent compounds and microtubule dynamics assays 
a) Structures of Taxol, Fchitax-3, Flutax-2 and Alexa488-Epothilone B.  
b) A scheme of the TIRF microscopy-based microtubule dynamics assay. GMPCPP-stabilized 
microtubule seeds that contain fluorescent tubulin such as rhodamine tubulin (for visualization) 
and biotinylated tubulin (for surface attachment via NeutrAvidin), are immobilized on a plasma-
cleaned coverslip coated with biotinylated poly(L-lysine)-[g]-poly(ethylene glycol) (PLL-PEG-
biotin) which is coupled with NeutrAvidin. Microtubule growth from GMPCPP-stabilized seeds 
is initiated by adding either tubulin supplemented with fluorescent tubulin, or by adding 
unlabeled tubulin and GFP/mCherry-tagged-EB3. Microtubule plus and minus ends are indicated. 
c) Time-lapse images and representative kymographs illustrating microtubule growth from 
GMPCPP stabilized microtubule seeds in the presence of tubulin (15µM) supplemented with 3% 
rhodamine-labeled tubulin (upper panel) and in the presence of unlabeled tubulin (15µM) and 
mCherry-EB3 (20nM) (lower panel). Kymographs are representative of 5 independent 
experiments. 
d) Kymograph illustrating a stable rescue site formed in the presence of 15µM tubulin, 20nM 
mCherry-EB3 and 50nM Fchitax-3. Kymographs are representative of 3 independent 
experiments. 
e) Quantification (mean values) of the occurrence of stable rescue sites at the indicated 
compound concentrations. ND, not detected.  n=100 for control (N=6), n=35 (N=4), 79 (N=6), 45 
(N=4) for 50, 100 and 200nM of Fchitax-3, respectively, n=46 (N=4) and 28 (N=3) for Taxol and 
Flutax-2. Error bars represent SD.  
f) Fluorescence intensity measurement of single molecule of Fchitax-3 in two parallel chambers 
made on the same coverslip. In one chamber, microtubule dynamics assay was performed in the 
presence of GMPCPP stabilized microtubule seeds with 15µM tubulin, 20nM mCherry-EB3 and 
 
 
100nM Fchitax-3. The intensity of Fchitax-3 molecules bound to coverslip was analysed in a 
microtubule-free region (purple square in the upper panel). The other chamber was incubated 
with the same concentration of Fchitax-3 without the reaction mix (lower panel). Images are 
representative of 3 independent experiments 
g, h) Fluorescence intensities (g) and photobleaching time traces (h) of Fchitax-3 molecules 
immobilized on coverslips in solution of 100nM Fchitax-3 without the reaction mix (n=3546) or 
Fchitax-3 bound to coverslip during the microtubule dynamics assay (n=2014) in a separate 
chamber on the same coverslip. In (g), the measured values are shown by symbols,  and the 
corresponding fits to Gaussian distributions by lines. For comparison, we used the intensity of 
Fchitax-3 molecules transiently immobilized on the same coverslip during the reaction. Such 
molecules had the same intensity and showed the same single-step photobleaching behavior as 
the Fchitax-3 molecules immobilized in a separate chamber on the same coverslip in the absence 
of any additional components. 
i) Fluorescence intensities of single Fchitax-3 molecules bound to the coverslip during the 
reaction and of Fchitax-3 accumulations at stable rescue site (symbols); the corresponding fits to 
Gaussian distributions are shown with lines.  
j) Fluorescence intensity (mean ± SD) of single Fchitax-3 molecules and the Fchitax-3 
accumulations at dot-like stable rescue sites, normalized to single molecule intensity. n=30, N=4 
independent experiments; error bar represents SD; ***p=0.0006, Mann–Whitney U-test. 
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Supplementary Figure 2: Formation of taxane accumulations at growing microtubule ends. 
a) Representative kymographs (N = 3 experiments) showing Flutax-2 accumulation at the plus- 
and the minus end of a microtubule (white arrows in the merge panel) in the presence of 15μM 
tubulin, 20nM mCherry-EB3 and 100nM Flutax-2. 
b) Plot showing the analysis of the time interval between the appearances of two consecutive 
accumulations. 64 consecutive accumulation events from 5 independent experiments were 
analysed and relative frequencies of different interval durations were plotted. 
c) Plots (mean values) showing quantification of the duration of Fchitax-3 accumulations (n=25, 
****p <0.0001), length of Fchitax-3 accumulations (n=29, ***p <0.0003) and the frequency of 
Fchitax-3 accumulations, calculated per unit of microtubule length  (n=40 for plus end and 45 for 
minus end, ****p <0.00001) at microtubule plus- and the minus ends. N=5 independent 
experiments, error bars represent SD, Mann–Whitney U-test. 
d, e) Maximum projection (upper panels), time lapse images (lower panels) (d) and representative 
kymographs (e) illustrating an Fchitax-3 accumulation event (white arrows) in a HeLa cell 
transfected with EB3-TagRFP and incubated with 100nM Fchitax-3 for 1 hr. Images are 
representative of 2 independent experiments. 
f) Representative kymographs (N = 3 experiments)  illustrating perturbation of microtubule 
growth during Fchitax-3 accumulation events (white arrows in the tubulin and Fchitax-3 panels) 
in the presence of 15μM tubulin, supplemented with 3% rhodamine-tubulin, and 100nM Fchitax-
3. 
g) Representative kymographs (N = 2 experiments) illustrating a stable rescue site (highlighted 
by stippled white line) and perturbed microtubule growth (whites arrows) in the presence of 
15μM tubulin, supplemented with 3% rhodamine-tubulin and 100 nM Taxol.  
 
 
h) Kymograph illustrating microtubule growth perturbation in the presence of 15µM tubulin, 
20nM mCherry-EB3 and 100nM Taxol. The right panel shows the quantification (mean values) 
of microtubule growth rate before (n=35), during (n=51) and after (n=51) the perturbed growth 
episode. N=3 independent experiment, Error bars represent SD, p <0.0001, Mann–Whitney U-
test.  
i) A scheme and still images (representative of 3 independent experiments) illustrating laser 
ablation of a control microtubule in the presence of 15μM tubulin, supplemented with 3% 
rhodamine-tubulin and 20nM mCherry-EB3. The region of laser ablation is indicated by a 
lightning bolt and a white oval. The asterisks show the position of the GMPCPP seed. 
Microtubule plus- and minus ends are indicated.  
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Supplementary Figure 3: Synthesis and characterization of Alexa488-Epothilone B. 
a) A scheme showing the reagents used for the synthesis of alexa-488 labelled epothilone B (see 
Methods for details). 
b)  Characterization of Alexa488-Epothilone B by NMR spectroscopy. 
1H-NMR (400 MHz, Acetonitrile-d3: D2O (9:1)) δ 8.39 (s, 1H), 7.94 (dd, J = 8.1, 1.7 Hz, 1H), 
7.80 (s, 1H), 7.60 (s, 1H), 7.40 – 7.32 (m, 1H), 7.28 (d, J = 7.8 Hz, 1H), 7.18 (s, 1H), 7.08 (d, J = 
9.2 Hz, 1H), 6.88 (d, J = 9.3 Hz, 1H), 6.54 (s, 1H), 5.50 (s, 1H), 5.45 – 5.31 (m, 1H), 4.31 (t, J = 
7.0 Hz, 1H), 4.27 – 4.18 (m, 1H), 3.64 (s, 3H), 3.37 (t, J = 7.1 Hz, 1H), 3.27 – 3.22 (m, 1H), 2.87 
(d, J = 11.1 Hz, 1H), 2.63 (s, 3H), 2.42 – 2.36 (m, 1H), 2.15 (d, J = 9.5 Hz, 1H), 2.04 – 1.98 (m, 
3H), 1.85 (s, 1H), 1.80 (s, 3H), 1.66 – 1.17 (m, >20H*), 1.00 –0.85 (m, >5H*). Due to the limited 
solubility of GS-244 across a range of solvents, no high quality spectrum could be recorded. 
Peaks labeled with an asterisk could not be assigned or integrated reliably. 
13C-NMR (126 MHz, DMSO-d6) δ 216.16, 170.32, 164.86, 164.48, 152.20, 151.05, 149.30, 
146.90, 137.36, 136.30, 136.22, 134.95, 133.98, 133.34, 133.26, 130.27, 130.16, 129.04, 128.85, 
128.17, 127.84, 124.31, 121.68, 117.82, 114.17, 105.23, 76.90, 70.52, 61.63, 61.38, 53.34, 52.82, 
49.74, 49.21, 47.03, 40.02, 39.85, 39.69, 39.52, 39.35, 39.19, 39.02, 35.61, 32.95, 32.58, 30.07, 
29.81, 29.61, 28.88, 25.97, 25.71, 24.95, 22.34, 22.19, 19.48, 18.96, 18.30, 14.30. Due to the 
limited solubility of GS-244 across a range of solvents, no high quality spectrum could be 
recorded. The signals listed were cross-checked by HMBC and HSQC spectroscopy, but several 
quaternary carbons were not observable. 
IR (film): 3298, 2926, 2859, 1726, 1643, 1619, 1548, 1444, 1319, 1252, 1187, 1156, 1052.  
??????= -20.3° (c = 0.148 in MeCN: H2O (1:1)).  
HRMS (MALDI/ESI): calcd for C59H74N7O16S3 [M+H+]: 1232.4349; found: 1232.4355.  
 
 
The number of scans for the 13C experiment is 32,000 and for the 1H experiment was 256. The 
click reaction itself was performed 2 times. 
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Supplementary Figure 4: Control of the formation of Fchitax-3 accumulations by 
microtubule dynamics. 
a) Representative kymographs (from 3 independent experiments) illustrating microtubule growth 
from GMPCPP stabilized microtubule seeds in the presence of increasing tubulin concentrations 
(10 to 25µM) and mCherry-EB3 (20nM). White arrows indicate events of perturbed microtubule 
growth at higher tubulin concentration. 
b) Quantification (mean values) of microtubule growth rates (left panel) and catastrophe 
frequencies (right panel) in the presence of 10, 15 and 25µM tubulin. n = 80, 92 and 124 growth 
events from 31, 25 and 25 microtubules for 10, 15 and 25µM tubulin, respectively. Catastrophe 
frequencies were quantified as an inverted average growth time per microtubule. Error bars 
represent SD, N=3 independent experiments. ****p <0.0001, Mann–Whitney U-test. 
c) Quantification (mean values) of microtubule growth rates (left panel) and the lengths of 
Fchitax-3 accumulations (right panel) in the presence of different concentrations of tubulin with 
mCherry-EB3 (20nM) and Fchitax-3 (100nM). n = 105, 101, 90 and 94 for growth rates and n = 
16, 21, 30 and 31 for the length of Fchitax-3 accumulations for 8, 10, 15 and 25µM of tubulin, 
respectively. Error bars represent SD, N=3 independent experiments, **p <0.003, ****p 
<0.0001, Mann–Whitney U-test.  
d) Representative kymographs (from 5 independent experiments) illustrating the occurrence of 
Fchitax-3 accumulation close to the GMPCPP-stabilized seed (white arrow in the merged panel). 
The assay was performed in the presence of 15μM tubulin, 20nM mCherry-EB3 and 100nM 
Fchitax-3.  
e) Representative kymographs (from 5 independent experiments) and the respective intensity 
profile depicting the reduction in the EB3 signal (white arrow in the kymograph) before the onset 
of a catastrophe. 
 
 
 
f) Quantification (mean values) of microtubule plus end catastrophe frequency (n=36) for control 
microtubules (15µM tubulin, 20nM EB3) and the frequency of Fchitax-3 accumulations at the 
plus ends (n=26) in the presence of 100nM Fchitax-3 with 15µM tubulin and 20nM mCherry-
EB3. For comparing the accumulation frequency with catastrophe frequency, both types of events 
were analysed as a total number of events observed per unit of time per microtubule. Error bars 
represent SD. 
g) Representative kymographs showing microtubule dynamics in control conditions (15µM 
tubulin, 20nM mCherry-EB3) or in the presence of 100nM vinblastine or 5nM GFP-MCAK. Bar 
graphs (mean values) show the quantification of microtubule growth rates (left panel) and 
catastrophe frequencies (right panel), n = 92, 225, 163 and 175 for growth rates and n = 25, 25, 
30 and 32 for catastrophe frequencies for control microtubule plus end dynamics, minus end 
dynamics, or the plus end dynamics in the presence vinblastine or MCAK, respectively. 
Catastrophe frequencies were quantified as an inverted average growth time per microtubule. 
Error bars represent SD, N=3 independent experiments, ****p <0.0001, Mann–Whitney U-test.  
h) Catastrophe frequencies per microtubule (mean value) in the presence of tubulin (15µM) and 
Fchitax-3 (100nM) without (n=18) or with EB3 (20nM, n=24) and without (n=23) or with 
vinblastine (100nM, n=21). Catastrophe frequencies were quantified as an inverted average 
growth time per microtubule. Error bars represent SD, N = 3 independent experiments.  
i) Representative kymographs (from 3 independent experiments) illustrating microtubule 
dynamics in the presence of 15µM tubulin supplemented with 3% of rhodamine tubulin in the 
presence of 100nM Fchitax-3 and 100nM vinblastine. 
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Supplementary Figure 5: Analysis of the kinetics of Fchitax-3 accumulation. 
a) Left and middle panel: Characteristic photobleaching traces of Fchitax-3 under different 
imaging conditions. Fchitax-3 immobilized on a coverslip was exposed to low laser power (10% 
of maximum laser power, 16μW, 491nm laser line, with a 100ms exposure time, time-lapse 
acquisition every 2s), used for imaging shown in all our experiments, or with 100ms/stream 
acquisition with the laser power of 16, 90 and 160 (100% laser power) μW. Curves were fitted 
with one-phase exponential decay. Right panel: Characteristic decay time (tau) for different 
conditions measured from one-phase exponential decay was plotted (mean values). N=4 
independent experiments, error bars represent SD. When images were acquired using 10% of 
maximum laser power (16µW, 491nm laser) with 100ms exposure and the interval of 2s (our 
experimental conditions), Fchitax-3 intensity profile showed 22±8% reduction over 600s, 
whereas we observe ~60% loss of Fchitax-3 signal within 200s (see Fig. 4a). In our experimental 
conditions, the characteristic time of Fchitax-3 desorption (corresponding to inverse of rate 
constant k3) desorption  ~100s is five time faster than the characteristic time of photobleaching, 
bleach ~500s.  
b) Schematic kinetic diagrams of the models used (see Methods for details).  
c) Comparison of the best fits to a single profile for the considered models.  
d) Dependence of initial values [Tureceptive] and [Tuunreceptive] tubulin states (Model 4) on the 
position along Fchitax-3 accumulation shown at Fig. 4a,c. 
e) Kinetics of [Tureceptive] tubulin state from Model 2 shown for profile in (c). 
f) Numerically solved FRAP curve generated from Model 2 fit shown in (c). 
 
 
g) Kinetics of [Tureceptive] and [Tuunreceptive] tubulin states from Model 4 shown for profile in (c). 
The plots (c-g) represent numerical solution of analytical equations with parameters taken from 
best fits to experimental curve shown in Fig. 4c. 
h) Histograms of fluorescence intensities (left panel) and mean integrated intensities (mean 
values, middle panel) of Fchitax-3 bound to coverslip during the reaction and Fchitax-3 at 
accumulation zones. Error bars represent SD, n=20, N=5 independent experiments. Right panel: 
analysis of the number of Fchitax-3 molecules in the regions of strong Fchitax-3 accumulation 
for 10 different microtubules. 
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Supplementary Figure 6: X-ray fiber diffraction of microtubules in the presence of taxol in 
different assembly conditions. 
a) Averaged and background subtracted microtubule diffraction image (example from 
microtubules assembled from GDP tubulin in the presence of Taxol, 4 independent experiments).  
b-f) Meridional planes of drug-free microtubules assembled from GTP-tubulin (black line in f), 
microtubules assembled from GTP-tubulin in the presence of Taxol (pre-assembly conditions, 
purple line in f) or GDP-tubulin in the presence of Taxol (blue line in f), and microtubules 
assembled from GTP-tubulin in the absence of Taxol and treated with Taxol after assembly (post-
assembly conditions, deep blue line in f). The red line in d shows the line considered for plotting 
the intensities in qx space. Panel f shows Meridional intensity patterns, with the inset illustrating 
the best fit of 1nm band experimental intensities to a Lorentzian distribution. Images are 
representative of 4 independent experiments. 
g) Fiber diffraction analysis of microtubules during different assembly conditions in the presence 
of Taxol. All Taxol-treated samples showed an 8 nm layer line, indicating a difference between 
α- and β-tubulin axial spacing and thus demonstrating that the observed dimer rise is due to 
differential monomer expansion. Data represent mean ± SEM. n=24, N=4 independent 
experiments.  
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Supplementary Figure 7: Analysis of Cryo-EM data and FRAP experiments. 
a-c) Representative Cryo-EM images (N = 2 independent experiments) illustrating the structure 
of GMPCPP-stabilized microtubule seeds (a),  microtubules grown from GMPCPP-stabilized 
microtubule seeds in the presence of 15µM tubulin, 20nM EB3 and 100nM vinblastine with (b) 
or without (c) 100nM Fchitax-3. White arrow shows the presence of a very small defect within 
GMPCPP-stabilized microtubule seeds. Scale bars, 50nm. 
d) Quantification (mean value) of percentage of Fchitax-3 accumulation found to be positive for 
CAMSAP3 binding. Error bars represent SD, n=27 accumulation events in 7 independent 
experiments, ND = not determined, as no such events were observed. 
e) A representative kymograph (left panel, N = 3 independent experiments) and fluorescence 
intensity profile (right panel) showing fluorescence recovery after photobleaching in a control 
microtubule (15µM tubulin supplemented with 3% rhodamine tubulin). The bleached 
microtubule region is highlighted by a red lightning bolt.  
f) Left panel: representative kymographs (N = 3 independent experiments) showing fluorescence 
recovery after photobleaching within microtubule lattice associated with Fchitax-3 accumulation 
(15µM tubulin supplemented with 3% rhodamine tubulin, 100nM Fchitax-3). The bleached 
microtubule region is highlighted by a white lightning bolt, and bleached microtubule area is 
shown by a white box. Robust tubulin incorporation within the bleached microtubule lattice 
associated with the Fchitax-3 accumulation zone is highlighted by white arrowheads. Right panel: 
fluorescence intensity profiles of an unbleached and a bleached microtubule region with and 
without Fchitax-3 accumulation. Strong recovery of fluorescence after bleaching within Fchitax-3 
accumulation region is highlighted by a red arrow. 
g) Representative kymographs (N = 5 independent experiments) showing transient EB3 binding 
(highlighted by red arrow in EB3 panel and white arrow in merged panel) within the Fchitax-3 
 
 
accumulation area. The experiment was performed in the presence of tubulin (15µM), mCherry-
EB3 (20nM) and Fchitax-3 (100nM). 
h) Distribution of the Fchitax-3 accumulation lengths observed in vitro. n=104 accumulation 
events from 7 experiments.  
 
Supplementary Video 1. Fchitax-3 accumulation at the growing microtubule plus end.  
The movie illustrates formation of an Fchitax-3 accumulation close to the growing microtubule 
plus end, as depicted in Fig. 2a. The experiment was performed in the presence of tubulin (15 
µM), mCherry-EB3 (20 nM) and Fchitax-3 (100 nM). The movie consists of 177 frames acquired 
with a 2s interval between frames and an exposure time of 100ms. Scale bar, 2µm. The movie is 
representative of more than 5 independent experiments. 
 
Supplementary Video 2. Laser severing experiment showing Fchitax-3 accumulation zone 
stabilizes microtubule lattice.  
The movie starts just after ablating the Fchitax-3 accumulation area with a 532nm laser as shown 
in Fig. 2h. After ablation of the growing microtubule at Fchitax-3 accumulation, both the newly 
generated ends survived and started growing again. The experiment was performed in the 
presence of tubulin (15µM, supplemented with 3% rhodamine-tubulin), mCherry-EB3 (20nM) 
and Fchitax-3 (100nM). The movie consists of 750 frames acquired in a stream acquisition mode 
with an exposure time of 100ms. Scale bar, 2µm. The movie is representative of 5 independent 
experiments. 
 
 
 
